MHRA Prepares For Safe Return To On-Site Inspections In UK
A Hybrid Model Of On- And Off-Site Activities Will Support A Single Inspection Cycle
Executive Summary
Four months after suspending all non-essential on-site inspections because of the COVID-19 pandemic, the UK medicines regulator is busy finalizing the practical arrangements needed to resume these safely at local sites.